Stanford University
Showing 151-200 of 228 Results
-
Marco Perez
Associate Professor of Medicine (Cardiovascular Medicine)
BioDr. Marco Perez's research goal is to better understand the fundamental causes of cardiovascular disease through the study of genetics and epidemiology. His group studies the genetic variations and environmental exposures that are associated with conditions such as atrial fibrillation and heart failure. He has led the studies of atrial fibrillation in Women's Health Initiative, one of the largest nation-wide population-based cohorts. He is currently conducting a large study monitoring for silent or asymptomatic atrial fibrillation in women from the WHI randomized to exercise intervention, and was co-PI of the Apple Heart Study, a clinical trial that validated the ability of a smartwatch to detect atrial fibrillation. He is now PI of the Clinical Coordinating Center at Stanford for the REACT-AF which is a clinical trial to evaluate efficacy and safety of a "pill-in-the pocket" approach to anticoagulation for AF using a smartwatch. He is interested in understanding the paradox that atrial fibrillation is less common in African Americans and Hispanics, despite a greater burden of risk factors such as hypertension. As director of the Stanford Inherited Arrhythmia Clinic, he evaluates families with rare inherited arrhythmias associated with sudden death such as Long QT and Brugada Syndromes and explores their links with novel genes. He also studies the genetic causes of very early onset atrial fibrillation. He also studies how best to use the electrocardiogram and imaging modalities using Machine Learning techniques to identify patients at risk for cardiovascular disease. Dr. Perez receives funding from the NIH/NHLBI, Apple Inc., Janssen and the Colson Foundation.
-
Alexander C. Perino
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioAlexander C. Perino MD is a cardiac electrophysiologist, clinical informaticist, and cardiovascular researcher. In his clinical role, Dr. Perino treats patients with heart rhythm disorders at Stanford Health Care, performing catheter ablations and cardiac device implantations. In addition to complex ablation (e.g., atrial fibrillation and ventricular tachycardia ablation), Dr. Perino has expertise implanting leadless pacemakers, subcutaneous ICDs, and conduction system pacing leads (i.e., His bundle and left bundle branch area pacing leads). Dr. Perino is the medical informatics director for the Division of Cardiovascular Medicine at Stanford Health Care, providing informatics direction to improve 1) the quality and safety of cardiovascular care delivery and 2) patient and clinician experience derived from the electronic health record and related information and communication technologies. As a cardiovascular researcher, Dr. Perino uses large datasets to examine quality of care, outcomes, and risk prediction for heart rhythm disorders and cardiovascular disease.
-
Richard Popp
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsAcademic-Industrial relations; Ethics of invention.
-
Thomas Quertermous, MD
William G. Irwin Professor of Cardiovascular Medicine
Current Research and Scholarly InterestsUnderstanding genetic basis of cardiovascular function and disease.
-
Sameer Raina, MD, MBBS, MBA, FACC
Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioDr. Raina is a board-certified cardiologist in the General Cardiology clinic at Stanford Health Care and a member of the Stanford Cardiovascular Institute. He is also a clinical associate professor in the Division of Cardiovascular Medicine.
His clinical interests include preventive cardiology, cardiac rehabilitation, and sports cardiology. In his recent positions at West Virginia University, he established the cardiology telemedicine program during and after the COVID pandemic. He applied his passion for cardiac rehab by creating individualized treatment plans for college athletes recovering from COVID. Dr. Raina is also passionate about building relationships with community doctors. He believes continuous communication is an essential part of excellent patient care.
Dr. Raina’s current research focuses on preventive cardiology, cardiac imaging, and outcomes research. He studies the outcomes of different cardiac interventions in specific patient populations. His research helps identify appropriate treatments for patients who have other conditions in addition to heart disease.
Dr. Raina eagerly anticipates joining the faculty of the Stanford South Asian Translational Heart Initiative (SSATHI). He is excited for the opportunity to address the high risk of cardiovascular diseases among South Asians. He looks forward to applying his clinical and research experience to support SSATHI’s mission to provide advanced care to ethnic populations disproportionately affected by these diseases.
Dr. Raina is a peer reviewer for several prestigious publications, including Neuropsychiatric Disease and Treatment and the International Journal of Chronic Obstructive Pulmonary Disease. He has also been an invited guest speaker at national and international meetings, including those for the International Congress of Cardiology and the World Congress of Cardiothoracic-Renal Diseases.
Dr. Raina is a fellow of the American College of Cardiology (FACC) and a member of the American College of Cardiology. -
Risheen Reejhsinghani
Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioRisheen Reejhsinghani obtained her medical degree in Mumbai, India, followed by an internal medicine residency at St. Elizabeth's Medical Center in Boston, MA and cardiology fellowship at Baystate Medical Center/Tufts University School of Medicine, where she served as one of the chief fellows. She subsequently completed an advanced echocardiography fellowship at the University of California, San Francisco, and is board certified in echocardiography, general cardiology, and nuclear cardiology.
Dr. Reejhsinghani practices as a general cardiologist in the Division of Cardiovascular Medicine at Stanford University School of Medicine, where she also serves as the associate director for the hospital-based consultative cardiology service. As a clinical cardiologist, she believes strongly in the tenets of evidence-based practice, diagnostic cognizance, and patient education. She also has a specific interest in the burgeoning field of Cardio-Rheumatology, focused on cardiac diseases among patients with rheumatologic conditions such as rheumatoid arthritis, systemic lupus erythematosus, scleroderma, and ankylosing spondylitis, among others. Her clinical research in this area has focused on the evaluation of structural cardiac disease and diastolic dysfunction in ankylosing spondylitis patients, primarily using echocardiography.
Dr. Reejhsinghani has an academic focus in medical education, and believes that instilling a love for bedside medicine and the physical exam is the soundest way to empower future generations of learners. To this end, she received additional training in clinical teaching and simulation at the University of California, San Francisco, and has worked extensively on curriculum and course design. She currently serves as the associate program director of the cardiovascular medicine fellowship at Stanford, and is an associate course director for the Year 1 Practice of Medicine Course at the Stanford University medical school. Dr. Reejhsinghani also enjoys writing, particularly about medical education and has written articles for international newspapers, among other publications. -
Stanley G. Rockson, MD
Allan and Tina Neill Professor of Lymphatic Research and Medicine
Current Research and Scholarly InterestsMy clinical research includes studies on risk factor modification in atherosclerosis and coronary artery disease; clinical trials involving medical therapies for peripheral arterial insufficiency; coronary angiogenesis; therapy of lymphedema; atherand photodynamic therapy in atherosclerosis.
-
Fatima Rodriguez
Associate Professor of Medicine (Cardiovascular Medicine)
BioFatima Rodriguez, MD, MPH is an Associate Professor in Cardiovascular Medicine and (by courtesy) the Stanford Prevention Research Center. Dr. Rodriguez earned her medical degree from Harvard Medical School and her MPH from the Harvard School of Public Health. She then completed internal medicine residency at Brigham and Women’s Hospital and fellowship in cardiovascular medicine at Stanford University. She currently serves as the Section Chief of Preventive Cardiology. Dr. Rodriguez specializes in cardiovascular disease prevention, inherited lipid disorders, and cardiovascular risk assessment in high-risk populations.
Dr. Rodriguez’s research includes a range of topics around racial, ethnic, and gender disparities in cardiovascular disease prevention, developing novel interventions to address disparities, and opportunistic screening of coronary artery disease. -
Albert "A.J." Rogers, MD, MBA, FAHA
Instructor, Medicine - Cardiovascular Medicine
BioDr. Rogers is a board-certified, fellowship-trained cardiologist with the Cardiac Arrhythmia Service at Stanford Health Care. He is also an instructor of medicine in the Division of Cardiovascular Medicine, Department of Medicine at Stanford University School of Medicine.
As a clinical cardiac electrophysiologist, Dr. Rogers’ training includes evaluating issues involving electrical activity in the heart and how these can lead to an abnormal heart rhythm (arrhythmia). His expertise includes mapping regions in the heart associated with arrhythmias and then applying a minimally invasive therapy (ablation) that targets the responsible areas causing the problem. He also performs procedures to implant cardiac devices, such as pacemakers and defibrillators, designed to synchronize heart contractions and reset irregular heartbeats.
Dr. Rogers specializes in the diagnosis and treatment of atrial fibrillation, ventricular tachycardia, and other arrhythmias. In collaboration with Stanford Medicine cardiovascular surgeons, he performs hybrid surgical-catheter ablation procedures as a more permanent treatment for persistent forms of atrial fibrillation and for inappropriate sinus tachycardia. During this procedure, ablation therapy is applied to areas both inside and outside of the heart responsible for the arrhythmia.
As a physician-researcher, Dr. Rogers’ translational research applies biomedical engineering and machine learning approaches to explore the mechanisms underlying cardiac arrhythmia. These efforts include research funded by the National Institutes of Health and the American Heart Association to investigate novel methods for diagnosing and treating heart rhythm disorders. Dr. Rogers has over 10 years of experience with medical technology innovation and development.
Dr. Rogers serves as associate editor of the Journal of Invasive Cardiovascular Electrophysiology. He is also a peer reviewer for multiple prestigious journals, including Heart Rhythm, The Lancet: Digital Health, the Journal of the American College of Cardiology: Clinical Electrophysiology, and Frontiers in Physiology. He has been an invited guest speaker at national and international meetings, including those for the American Heart Association and the European Cardiac Arrythmia Society. -
Heidi Salisbury
Casual Employee, Medicine - Med/Cardiovascular Medicine
BioHeide Salisbury, CNS is a clinical nurse specialist who works at the Stanford Heart Failure and Cardiomyopathy Clinic.
-
Karim Sallam, MD
Assistant Professor of Medicine (Cardiovascular Medicine)
BioKarim Sallam, MD, is trained in Cardiovascular Medicine and Advanced Heart Failure.
-
Ryan Sandoval, M.D.
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Sandoval is a board-certified cardiologist and a clinical assistant professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine. He completed his residency at the University of Texas at Austin, where he continued on as chief resident before going on to complete his fellowship in cardiovascular disease at the Medical University of South Carolina. Prior to his residency, he completed a research fellowship at Massachusetts General Hospital (MGH).
His clinical interests include preventive cardiology and management of heart failure. He is particularly focused on treating patients with the complex clinical syndrome of heart failure with preserved ejection fraction (HFpEF).
His interest in preventive cardiology grew through his participation in clinics for the uninsured and underinsured during his training. These experiences fostered his passion for understanding and addressing health care disparities. He is deeply committed to providing exceptional patient care with a personalized approach to treatment and improving the lives of his patients.
He is a member of the American College of Cardiology. -
Ingela Schnittger, MD
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsMy main research continues to be in the field of echocardiography. Several areas of research are currently being pursued.
-
John S. Schroeder, MD
Professor (Clinical) of Medicine (Cardiovascular), Emeritus
Current Research and Scholarly Interests1. Clinical Pharmocology of Cardiovascular Drugs
(a) Calcium Channel Blockers
(b) Agents for Heart Failure
(c) Anti-atherosclerotic Effects of Cardiovascular Drugs, e.g. Calcium Channel Blockers
2. Cardiac Transplantation/Congestive Heart Failure
3. Coronary Artery Spasm -
Katharine Sears Edwards
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsPotential impact of brief behavioral interventions to improve adjustment, coping, medical adherence, and cardiovascular health among cardiac patients.
Psychosocial challenges of patients with spontaneous coronary artery dissection (SCAD).
Assessment and training in evidence-based psychological therapies. -
Disha Sharma
Postdoctoral Scholar, Cardiovascular Medicine
BioI am currently a Postdoctoral Fellow with Dr. Thomas Quertermous at Stanford University. I have joined the lab with more than 7 years of research experience in the field of computational biology wherein I have worked with multi-omics data for multiple diseases to get a deeper understanding of the disease identification and progression.
My background in engineering and bioinformatics provide an excellent background for the studies proposed in this application, which proposes to investigate the genetics and genomics of smooth muscle cell biology in the context of vascular disease. I first pursued a Bachelor's in Biotechnology program at one of the premier institutes in India, Banasthali Vidyapeeth and received my degree in 2007. After qualifying with the IIT-JAM exam in 2010, I joined the Master’s in Science (Biotechnology) program at the prestigious Indian Institute of Technology Roorkee in a program of engineering and technology. After my Master's, I joined Dr. Vinod Scaria’s lab at CSIR-IGIB as a Project Fellow. During the tenure as Project fellow from 2012-2014, I had the opportunity to work with different transcriptomics data from model organisms including zebrafish, rat and human cell lines to understand the role of long non-coding RNAs and miRNAs. I also worked on clinical datasets of autoimmune disorders. With one and half years of research experience and a UGC fellowship awarded through the NET-JRF examination, I continued working with Dr. Vinod Scaria to pursue my PhD. My research interest for the degree focused on the identification and characterization of circular RNAs, and this work has now been published in multiple manuscripts listed below. Over the years at CSIR-IGIB, I have had the chance to work on interesting ideas with multiple collaborating groups. One of them was Dr. Sridhar Sivasubbu, with whom I worked to understand the transcript-level interactions between mitochondria and the nucleus, using zebrafish as a model organism.
In view of my interest in the translational aspects of biology, I obtained the opportunity to work as part of the GUaRDIAN Consortium with Dr. Vinod Scaria and Dr. Sridhar Sivasubbu at CSIR-IGIB. This pioneering project is the largest network of researchers and clinicians in India pursuing sequencing patient DNAs to identify rare SNVs and structural variants responsible for muscular dystrophy in these patients. In the interest of advancing genomics in clinical and healthcare settings, I was selected as Intel Fellow 2019 to work for the Intel-IGIB collaboration focussing on “Accelerating Clinical Analysis and Interpretation of Genomic Data through advanced tools/libraries”. Our project was selected among top 3 from 50 premier research institutes and I was awarded the Intel-India Fellowship for a year to pursue this project. I was also part of the core team of IndiGen (Genomes for Public Health in India). With the spread of COVID-19 around the world, our group contributed by sequencing and analysing COVID19 genomes to get a better understanding of the disease and I had the opportunity to be part of the core team to analyse the viral sequencing datasets and viral assembly.
I am extremely pleased to have joined the Quertermous lab at Stanford to the study of the molecular mechanisms of cardiovascular disease. Work that I am pursuing in this laboratory, and proposed in this application, are directly in line with my personal aspiration to start an independent career in the field of scientific research to work on projects with high translational value and of interest to the public health. -
Rahul P Sharma, MBBS, FRACP
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsTranscatheter valve therapies, CT valve imaging, AI and device innovation
-
Joshua M. Spin
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsDr. Spin began his research career studying the structural biology of low density lipoprotein, and has been augmenting his skills with intensive training in molecular biology techniques, particularly those involving high-throughput genetic expression profiling. He is especially interested in vascular smooth muscle cells, and the role of smooth muscle differentiation and phenotypic switching in development and vascular disease. His latest work has focused on the biology of aortic aneurysms.
-
Jeffrey Teuteberg
Professor of Medicine (Cardiovascular Medicine)
BioHe is currently a Professor of Medicine at Stanford where he serves as the Section Chief of Heart Failure, Cardiac Transplantation, and Mechanical Circulatory Support. He sees patients both in the clinic and in the hospital who have advanced heart failure or who have received cardiac transplantation or mechanical circulatory support.
His research interests are in clinical outcomes in patients after transplant and mechanical support as well as novel approaches to immunosuppression. He has participated in many single-center and multi-institutional research studies and has published widely in the fields of transplant and mechanical support. He served as President of the International Society of Heart and Lung Transplantation in 2018. -
Lindsay Thomas, RN, MS, CNS
Affiliate, Medicine - Med/Cardiovascular Medicine
BioMs. Lindsay Thomas earned her BA in Integrative Biology from UC Berkeley in 2003 and her RN and MS from UCSF in 2006 and 2009 respectively. She completed a Double Master’s in Cardiovascular Nursing and Genomics and is a board certified clinical nurse specialist in critical care nursing. She joined the Stanford Interventional Cardiology Team in 2011 where she has pioneered the advanced practice nursing role in the cath lab and been a leader in the development of the Left Atrial Appendage Closure program. She serves as adjunct faculty for the UCSF graduate nursing program and is the co-chair of the Northern California Chapter of the Preventative Cardiovascular Nurses Association. Lindsay specializes in treating and caring for patients with established coronary artery disease and cardiovascular risk factors; she strives to provide excellent patient care and education to optimize a heart healthy life style to promote wellness with use of medications and invasive procedures when life style alone is not enough to achieve desired results. When not working Lindsay is an outdoor and exercise enthusiast, who enjoys participating in various endurance activities and has completed several triathlons. She also enjoys reading and discussions with her book club, going to the theater, and spending quality time with her friends and family.
-
Alexander Tolas
Clinical Research Coordinator, Medicine - Med/Cardiovascular Medicine
BioI’m passionate about the many intersections between health, technology, and behavior. Specifically with how wearable devices and mobile technologies can be leveraged to measure and promote better health outcomes across all populations. After earning my BS in Kinesiology, I have formed a strong analytical background in wearable technology and health through my involvement in numerous clinical health studies and research projects. To supplement my interest, I have had multiple academic pieces accepted by Medicine & Science in Sports & Exercise (MSSE) and The Journal for the Measurement of Physical Behaviour (ISMPB).
-
Jennifer Tremmel
Susan P. and Riley P. Bechtel Medical Director and Associate Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Tremmel studies sex differences in cardiovascular disease. Current research projects include evaluating sex differences in coronary pathophysiology, young patients presenting with myocardial infarction, the impact of stress on anginal symptoms, chronic total coronary occlusions, and vascular access site complications.
-
Philip S. Tsao, PhD
Professor (Research) of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsOur primary interests are in the molecular underpinnings of vascular disease as well as assessing disease risk. In addition to targeted investigation of specific signaling molecules, we utilize global genomic analysis to identify gene expression networks and regulatory units. We are particularly interested in the role of microRNAs in gene expression pathways associated with disease.
-
Jason V. Tso, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Tso is a board-certified cardiologist with the Sports Cardiology Program and the Center for Inherited Cardiovascular Disease. He serves as medical director of the Sports Cardiology Program and is a clinical assistant professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine.
As a noninvasive cardiologist with clinical expertise in sports cardiology, Dr. Tso specializes in treating physically active patients. He cares for recreational weekend warriors, elite and professional athletes, and all those in between.
He has experience caring for athletes from professional sports teams and multiple National Collegiate Athletic Association (NCAA) Division I universities. Dr. Tso currently performs cardiac screening and consultations for Bay Area professional sports teams and the NCAA Division I athletes of Stanford University Athletics.
Dr. Tso’s research interests include cardiovascular health and adaptation in athletes. He has spent years studying American-style football players and Masters endurance athletes. He has presented his research at multiple national meetings, including the American College of Cardiology Scientific Sessions, American Heart Association Scientific Sessions, and the national meeting of the Heart Failure Society of America.
Dr. Tso’s research has been published in multiple peer-reviewed journals, including the Journal of the American Heart Association, the European Journal of Preventive Cardiology, and the British Journal of Sports Medicine. He also regularly serves as a reviewer for several cardiology and sports medicine journals. -
Randall Vagelos, MD
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsI. Congestive Heart Failure New Medical Therapies Prognostic Evaluation Selection for Cardiac Transplantation II. Screening for Myocardial Necrosis New ECG Monitoring Devices New Serum Markers III. Screening for CAD Patients Who Have Received Radiation Rx Diabetics Being Considered for Renal Transplantation
IV. Advanced coronary and valvular disease, evaluationg candidacy for high risk interventions. -
Hannah Valantine
Professor of Medicine (Cardiovascular)
On Leave from 09/01/2024 To 08/31/2025Current Research and Scholarly InterestsMy lab is focused on understanding the mechanism mediating acute and chronic allograft failure, in particular on the role of microvascular injury in acute allograft failure and the mechanisms of mediating transplant coronary artery disease. 1. Role of microvascular injury in acute allograft failure.
-
Laurens van de Wiel
Postdoctoral Scholar, Cardiovascular Medicine
BioLaurens van de Wiel is Dutch scientist from Berghem, The Netherlands. Laurens spent his undergrad in Software Development (BSc, Avans Hogeschool ‘s-Hertogenbosch) and Computing Science (MSc, Radboud University Nijmegen). Laurens continued his career at a start-up, where he created large-scale, real-time analytical software. Laurens continued on his academic trajectory at the Radboudumc in Nijmegen, where he started his PhD in bioinformatics.
During his PhD, Laurens integrated genetic data with protein 3D structures and protein domains. He utilized the skills he obtained before setting out on his academic trajectory; building large-scale, robust, reliable software. Exemplified by the MetaDome Web server (https://stuart.radboudumc.nl/metadome/). During his PhD, he developed novel methodologies for the interpretation of genetic variants of unknown clinical significance and, by integrating structural and evolutionary biology with genomics, Laurens identified 36 novel disease-gene associations for developmental disorders. These discoveries enabled diagnosis for over 500 families worldwide.
Laurens’ areas of expertise are (bioinformatic) software development, data integration of genetic variation with other omics, and his research aims are:
1.) Lessons long-learned in computer science aid computational biology
2.) Multi-omic data integration allows the impact measurement of genetic variation
3.) Diagnosing undiagnosed disorders will uncover novel insights into biology.
4.) International and multidisciplinary collaborations are key in diagnosing rare disorders.
At Stanford University, under guidance of Dr. Matthew Wheeler, he is conducting his postdoctoral studies in line with his research aims. -
Anubodh Sunny Varshney
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Anubodh Sunny Varshney is a Clinical Assistant Professor and Associate Director of the fellowship program in the section of Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford. In addition to caring for patients with advanced heart disease, he is also an Investigator in the Cardiovascular Outcomes, Policy, & Implementation Research Group (https://www.copirgroup.com/) where he works to identify patient groups that have ongoing unmet medical needs, define benchmark outcomes that next generation therapies should improve upon, and understand factors that influence adoption of novel drug and device therapies.
Dr. Varshney earned a BS in biomedical engineering from Washington University in St. Louis and an MD from the University of Texas Southwestern Medical School. He completed residency in Internal Medicine and fellowship in Cardiovascular Medicine at Brigham & Women’s Hospital/Harvard Medical School and fellowship in Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford University.
Dr. Varshney also has experience advising multiple medical device, drug, and digital health start-ups and currently serves as a Venture Advisor at Broadview Ventures, a philanthropically-funded, mission-driven investment organization that invests in early-stage companies developing technologies that have the potential to improve outcomes for patients with cardiovascular disease or stroke.
